Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05150990 · ClinicalTrials.gov registry record · NA
Technology and Family Thriving Study
A NA study of Alzheimer Disease and Dementia, sponsored by University of California, Santa Barbara.
- Completed
- Registry status
- NA
- Development phase
- 186
- Enrollment target
- 20
- Study locations
NCT05150990: Completed NA study of Alzheimer Disease and Dementia, sponsored by University of California, Santa Barbara.
NCT05150990 is a NA study of Alzheimer Disease and Dementia that has completed, run by University of California, Santa Barbara. The registered enrollment target is 186 participants, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (93% lower). The trial reports 20 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05150990, a NA study of Alzheimer Disease and Dementia, has completed, sponsored by University of California, Santa Barbara.
- COMPLETED
- Registry status
- NA
- Development phase
- 186 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this project is to test the impact of different forms of technology (virtual reality vs. video chat) on quality of life and family relationships in older adults who reside in senior living communities and an adult child who lives at a distance. The study will also investigate whether responses to the technology and quality of life outcomes depend on older adults' level of cognitive impairment.
Primary Outcome
QOL-AD (R.G. Logsdon, 1996) is a 13-item self-report measure of quality of life (completed by older adult participants). (As a secondary outcome, adult children also reported on their parents' quality of life). Items are rated on a 4-point scale: 1 = Poor, 2 = Fair, 3 = Good, 4 = Excellent. The total score is the mean of all items (range: 1 to 4). Higher scores indicate greater quality of life.
Conditions Studied
Interventions
- BEHAVIORAL Virtual Reality
- BEHAVIORAL Video Chat
Study Locations (20)
California
- Belmont Calabasas - Calabasas
- Oakmont of Camarillo - Camarillo
- Friendship Manor - Goleta
- Casa Dorinda - Montecito
- Ojai Gables - Ojai
- Garden Court on De La Vina - Santa Barbara
- Covenant Living at the Samarkand - Santa Barbara
- Gardens on Hope - Santa Barbara
- Grace Village Apartments - Santa Barbara
- Valle Verde - Santa Barbara
- Vista Del Monte - Santa Barbara
- Heritage House - Santa Barbara
- Maravilla - Santa Barbara
- Atterdag Village of Solvang - Solvang
Massachusetts
- Stone Hill at Andover - Andover
- Stonebridge at Burlington - Burlington
- Youville House Assisted Living - Cambridge
- Cadbury Commons - Cambridge
- Brightview Canton - Canton
- The Linden at Danvers - Danvers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 186 participants |
| Start Date | 2021-10-02 |
| Est. Completion | 2024-03-16 |
| Phase | NA |
What the finished NCT05150990 record still lists
NCT05150990 is an interventional study that assigns participants to a tested intervention. The registered 186 participants enrollment target is mid-sized for trials with a published cap, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (93% lower).
The record links to 7 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 2 interventions - of which Virtual Reality is the first listed.
NCT05150990 names 20 study sites across 2 states, led by California, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05150990 about?
NCT05150990 is a clinical study titled "Technology and Family Thriving Study". The purpose of this project is to test the impact of different forms of technology (virtual reality vs. video chat) on quality of life and family relationships in older adults who reside in senior living communities and an adult child who lives at a distance. The study will also investigate whether ...
What is the current status of trial NCT05150990?
This trial is currently completed. It is a NA study. The enrollment target is 186 participants. The study started on 2021-10-02. Estimated completion is 2024-03-16.
What conditions does trial NCT05150990 study?
This clinical trial studies the following conditions: Alzheimer Disease, Dementia, Quality of Life, Loneliness, Mental Health Wellness 1.
What interventions are being tested in trial NCT05150990?
The interventions under investigation include: Virtual Reality (BEHAVIORAL), Video Chat (BEHAVIORAL).
Who is sponsoring clinical trial NCT05150990?
This trial is sponsored by University of California, Santa Barbara, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05150990 being conducted?
This trial has 20 study locations across California, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimer Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05150990's enrollment target sits among peer trials
186 114th of 306 higher than 193 of 306 other Alzheimer Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alzheimer Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
RECRUITING · NA
-
Brain Outcomes With Lifestyle Change in Down Syndrome
RECRUITING · NA
-
Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
RECRUITING · NA
-
A Feasiblity Study of Green Activity Program for People Living With Memory Challenges
RECRUITING · NA
-
Connect-Home: Alzheimer's Disease and Related Dementias
RECRUITING · NA
-
Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03567889 · 186 participants · Phase 3
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
- NCT05281471 · 186 participants · Phase 3
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
- NCT05405595 · 186 participants · Phase 1
ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors
- NCT05762107 · 186 participants · Phase 2
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI